SEC Comment Letter for Aspira Women's Health Inc. (AWHL) (CIK 0000926617) (AWHL) — Oct 31, 2017
Aspira Women's Health Inc. (AWHL) (CIK 0000926617)
Date: Oct. 31, 2017 · CIK: 0000926617 · Accession: 0000000000-17-038527
AI Filing Summary & Sentiment
Reasoning
Letter
October 31, 2017 Valerie B. Palmieri Chief Executive Officer Vermillion, Inc. 12117 Bee Caves Road, Building Three, Suite 100 Austin, TX 78738 Vermillion, Inc. Registration Statement on Form S-3 Filed October 24, 2017 File No. 333-221092Re: Dear Ms. Palmieri: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Beth E. Peev, Esq.
Show Raw Text
October 31, 2017
Valerie B. Palmieri
Chief Executive Officer
Vermillion, Inc.
12117 Bee Caves Road, Building Three, Suite 100
Austin, TX 78738
Vermillion, Inc.
Registration Statement on Form S-3
Filed October 24, 2017
File No. 333-221092Re:
Dear Ms. Palmieri:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Beth E. Peev, Esq.